Home » Topics » BioWorld

BioWorld
RSS

PERSEPTIVE RAISES $6.75M IN FUNDING

Aug. 21, 1991

FIVE MORE SUITS FILED AGAINST XOMA

Aug. 21, 1991

COLLAGEN COMPLIES WITH LABELING CHANGES

Aug. 21, 1991

TWO COMPANIES TEST IPO MARKET

Aug. 21, 1991

AMGEN SELLS REAGENT, DIAGNOSTIC BUSINESSES

Aug. 21, 1991

INTERNEURON DEAL FOR ALZHEIMER'S DRUG

Aug. 20, 1991

CELTRIX UNDERWRITERS EXERCISE OPTION

Aug. 20, 1991

ICN SUBMITS NDA FOR ANTI-VIRAL

Aug. 20, 1991

INCSTAR TO SELL CELLULAR'S AIDS TEST

Aug. 20, 1991

BIOGROWTH GETS SBIR FOR LEANER MEAT

Aug. 20, 1991

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for June 17, 2026.
News in brief
BioWorld Asia
BioWorld Asia briefs for June 16, 2026
For clonal hematopoiesis, epigenetics can be in driver’s seat
BioWorld Science
Clonal hematopoiesis (CH), where few blood stem cells produce a significant fraction of mature blood cells that are genetically identical, is partly an inevitable...
Elixiron’s enrupatinib shows upbeat interim phase II AD results
BioWorld
Elixiron Immunotherapeutics Inc. announced positive interim open-label phase II Alzheimer’s disease (AD) study findings of enrupatinib, an oral brain-penetrant...
Gene replacement rescues autism-related phenotypes in mice
BioWorld Science
Autism spectrum disorder (ASD), developmental epileptic encephalopathies and other neurodevelopmental disorders are driven by the disruption of genes regulating...